Clinical Trial Update: Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclophosphamide and rabbit anti-thymocyte globulin with hematopoietic stem cell support in systemic sclerosis; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• RATG (rabbit anti-thymocyte globulin) (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Northwestern University | Conditions: SYSTEMIC SCLERODERMA | Phase 2 | Status: COMPLETED | Results posted: 2014-04-30